1887

Abstract

Introduction:

is the most common cause of human bacterial enteritis in developed countries and is a rare cause of extra-intestinal infections.

Case presentation:

In this paper, we report a case of septic arthritis related to infection in an immunocompetent 53-year-old man with prosthetic devices who presented to us with enteritis. Following treatment with ciprofloxacin, loperamide hydrochloride and acetaminophen, he developed articular pain with painful swelling and redness in the region of the outer side of the left thigh. A diagnosis of a monoarticular non-migratory manifestation was postulated and vancomycin was started but was stopped 1 day later due to the development of skin erythema, and levofloxacin, teicoplanin and rifampicin treatment was started. An X-ray of the hip excluded dislocation of the prosthesis, while ultrasound showed an abscess in the soft tissue, confirmed by a triphasic bone scan. Aspiration of the joint fluid revealed the presence of moving, curved, Gram-negative bacilli 72 h after incubation, while growth on agar plates and tryptose broth remained negative after 5 days. Reactions for diagnosis were positive, and the micro-organism was identified as . Antimicrobial susceptibility tests revealed a sensitivity for ampicillin, ciprofloxacin, imipenem, tetracycline, erythromycin and gentamicin. Antimicrobial treatment was continued for a further 10 days with complete resolution of symptoms.

Conclusion:

Clinicians should consider in infections without a history of a travel in the tropics. Antibiotic treatment must be carefully evaluated to take into account the local resistance to avoid clinical failure.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.000095
2015-10-09
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/2/5/jmmcr000095.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.000095&mimeType=html&fmt=ahah

References

  1. Berden J. H., Muytjens H. L., van de Putte L. B. 1979; Reactive arthritis associated with Campylobacter jejuni enteritis. BMJ 1:380–381 [View Article][PubMed]
    [Google Scholar]
  2. Bottieau E., Clerinx J., Vlieghe E., Van Esbroeck M., Jacobs J., Van Gompel A., Van Den Ende J. 2011; Epidemiology and outcome of Shigella, Salmonella and Campylobacter infections in travellers returning from the tropics with fever and diarrhoea. Acta Clin Belg 66:191–195[PubMed]
    [Google Scholar]
  3. Bremell T., Bjelle A., Svedhem A. 1991; Rheumatic symptoms following an outbreak of Campylobacter enteritis: a five year follow up. Ann Rheum Dis 50:934–938 [View Article][PubMed]
    [Google Scholar]
  4. Briedis D. J., Khamessan A., McLaughlin R. W., Vali H., Panaritou M., Chan E. C. 2002; Isolation of Campylobacter fetus subsp., fetus from a patient with cellulitis. J Clin Microbiol 40:4792–4796 [View Article][PubMed]
    [Google Scholar]
  5. Brzank M., Wollenhaupt J. 2013; [Infection-induced reactive arthritis: etiopathogenesis, clinical spectrum, therapy]. Z Rheumatol 72:977–985 (in German) [CrossRef]
    [Google Scholar]
  6. Bullman S., O'Leary J., Corcoran D., Sleator R. D., Lucey B. 2012; Molecular-based detection of non-culturable and emerging campylobacteria in patients presenting with gastroenteritis. Epidemiol Infect 140:684–688 [View Article][PubMed]
    [Google Scholar]
  7. Butzler J. P. 2004; Campylobacter, from obscurity to celebrity. Clin Microbiol Infect 10:868–876 [View Article][PubMed]
    [Google Scholar]
  8. Carter J. D., Hudson A. P. 2009; Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 35:21–44 [View Article][PubMed]
    [Google Scholar]
  9. Cone L. A., Dreisbach P. B., Hirschberg J., Shekar C., Dreisbach L. P., Salatich W. 2003; Cellulitis and septic arthritis caused by Campylobacter fetus and Campylobacter jejuni: report of 2 cases and review of the literature. J Clin Rheumatol 9:362–369 [View Article][PubMed]
    [Google Scholar]
  10. Crotti D., D'Annibale M. L. 2008; [Campylobacter enteritis and related organisms. Clinical microbiology and antibiotic resistance]. Recenti Prog Med 99:83–88 (in Italian) [PubMed]
    [Google Scholar]
  11. De Vuono A., Palleria C., Scicchitano F., Squillace A., De Sarro G., Gallelli L. 2014; Skin rash during treatment with generic itraconazole. J Pharmacol Pharmacother 5:158–160 [View Article][PubMed]
    [Google Scholar]
  12. Eastmond C. J., Reid T. M., Rennie J. A. 1981; Reactive arthritis associated with campylobacter enteritis. Ann Rheum Dis 40:431 [View Article][PubMed]
    [Google Scholar]
  13. Gallelli L., De Fazio S., Corace E., De Sarro G., Garcia C. S., De Fazio P. 2006; Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish. Pharmacopsychiatry 39:154–156 [View Article][PubMed]
    [Google Scholar]
  14. Gallelli L., Staltari O., Palleria C., De Sarro G., Ferraro M. 2009; Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf 4:204–206 [View Article][PubMed]
    [Google Scholar]
  15. Gallelli L., Maida F., Staltari O., Rende P., Russo E., Caroleo B., De Sarro G. 2015; Recurrence of atrial fibrillation after switching from brand to generic atenolol. J Pharmacol Pharmacother 6:39–41 [View Article][PubMed]
    [Google Scholar]
  16. Gareri P., De Fazio P., Cotroneo A., Lacava R., Gallelli L., De Fazio S., De Sarro G. 2007; Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient. Arch Gerontol Geriatr 44 (Suppl. 1:199–206 [View Article][PubMed]
    [Google Scholar]
  17. Gareri P., De Fazio P., Gallelli L., De Fazio S., Davoli A., Seminara G., Cotroneo A., De Sarro G. 2008; Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Ann Pharmacother 42:434–438 [View Article][PubMed]
    [Google Scholar]
  18. Garg A. X., Pope J. E., Thiessen-Philbrook H., Clark W. F., Ouimet J. 2008; Walkerton Health Study Investigators Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford) 47:200–204 [View Article][PubMed]
    [Google Scholar]
  19. Gumpel J. M., Martin C., Sanderson P. J. 1981; Reactive arthritis associated with campylobacter enteritis. Ann Rheum Dis 40:64–65 [View Article][PubMed]
    [Google Scholar]
  20. Hannu T., Mattila L., Rautelin H., Pelkonen P., Lahdenne P., Siitonen A., Leirisalo-Repo M. 2002; Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) 41:312–318 [View Article][PubMed]
    [Google Scholar]
  21. Hannu T., Kauppi M., Tuomala M., Laaksonen I., Klemets P., Kuusi M. 2004; Reactive arthritis following an outbreak of Campylobacter jejuni infection. J Rheumatol 31:528–530[PubMed]
    [Google Scholar]
  22. Ichiyama S., Hirai S., Minami T., Nishiyama Y., Shimizu S., Shimokata K., Ohta M. 1998; Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis 27:252–255 [View Article][PubMed]
    [Google Scholar]
  23. Iovine N. M. 2013; Resistance mechanisms in Campylobacter jejuni . Virulence 4:230–240 [View Article][PubMed]
    [Google Scholar]
  24. Joly P., Boissonnas A., Fournier R., Khalifa P., Vedel G., Cremer G. A., Languepin A., Kerboull M., Laroche C. 1986; [Septic arthritis caused by Campylobacter fetus]. Rev Rhum Mal Osteoartic 53:223–226 (in French)
    [Google Scholar]
  25. Keat A. 1983; Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 309:1606–1615 [View Article][PubMed]
    [Google Scholar]
  26. Locht H., Krogfelt K. A. 2002; Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli . Ann Rheum Dis 61:448–452 [View Article][PubMed]
    [Google Scholar]
  27. Mumoli L., Gambardella A., Labate A., Succurro E., De Sarro G., Arturi F., Gallelli L. 2014; Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol 15:3 [View Article][PubMed]
    [Google Scholar]
  28. Naranjo C. A., Busto U., Sellers E. M., Sandor P., Ruiz I., Roberts E. A., Janecek E., Domecq C., Greenblatt D. J. 1981; A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245 [View Article][PubMed]
    [Google Scholar]
  29. Pasticci M. B., Baratta E., Del Favero A., Gillio A., Baldelli F., Pauluzzi S. 1992; Campylobacter jejuni - an unusual cause of infectious arthritis. Postgrad Med J 68:151–152 [View Article][PubMed]
    [Google Scholar]
  30. Peterson M. C. 1994; Clinical aspects of Campylobacter jejuni infections in adults. West J Med 161:148–152
    [Google Scholar]
  31. Peterson M. C., Farr R. W., Castiglia M. 1993; Prosthetic hip infection and bacteremia due to Campylobacter jejuni in a patient with AIDS. Clin Infect Dis 16:439–440 [View Article][PubMed]
    [Google Scholar]
  32. Pönkä A., Pitkänen T., Pettersson T., Aittoniemi S., Kosunen T. U. 1980; Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand 208:495–496 [View Article][PubMed]
    [Google Scholar]
  33. Simon C. H., Markusse H. M. 1995; Campylobacter jejuni arthritis in secondary amyloidosis. Clin Rheumatol 14:214–216 [View Article][PubMed]
    [Google Scholar]
  34. Yao J. D., Ng H. M., Campbell I. 1993; Prosthetic hip joint infection due to Campylobacter fetus . J Clin Microbiol 31:3323–3324[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.000095
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.000095
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error